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Developing a Food Exposure and Urine Sampling Strategy
for Dietary Exposure Biomarker Validation in Free-Living
Individuals
Amanda J. Lloyd, Naomi D. Willis, Thomas Wilson, Hassan Zubair, Long Xie,
Edward Chambers, Isabel Garcia-Perez, Kathleen Tailliart, Manfred Beckmann,
John C. Mathers, and John Draper*
Scope: Dietary choices modulate the risk of chronic diseases and improving
diet is a central component of public health strategies. Food-derived
metabolites present in urine could provide objective biomarkers of dietary
exposure. To assist biomarker validation, this work aims to develop a food
intervention strategy mimicking a typical annual diet over a short period of
time and assesses urine sampling protocols potentially suitable for future
deployment of biomarker technology in free-living populations.
Methods and results: Six different menu plans comprehensively represent a
typical UK annual diet that is split into two dietary experimental periods.
Free-living adult participants (n = 15 and n = 36, respectively) are provided
with all their food, as a series of menu plans, over a period of three
consecutive days. Multiple spot urine samples are collected and stored at
home.
Conclusion: A successful food exposure strategy is established following a
conventional UK eating pattern, which is suitable for biomarker validation in
free-living individuals. The urine sampling procedure is acceptable for
volunteers and delivered samples suitable for biomarker quantification. The
study design provides scope for validation of existing biomarker candidates
and potentially for discovery of new biomarker leads, and should help inform
the future deployment of biomarker technology for habitual dietary exposure
measurement.
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1. Introduction
An unbalanced diet and physical inac-
tivity are important risk factors in the
development of chronic diseases includ-
ing cardiovascular diseases (CVD), type
2 diabetes, many cancers, dementia, and
musculoskeletal diseases and drive the
increase in obesity prevalence. Conse-
quently, improving dietary choices is a
cornerstone of national and international
strategies for reducing chronic disease
burden.[1,2] A key factor in effective imple-
mentation of public health strategies is
the need for validated population screen-
ingmethods with which to determine the
effectiveness of interventions to change
individual’s dietary intake and the effec-
tiveness of industry to improve the com-
position of foods, meals, and diets. For
a clear understanding of the relation-
ship between food exposure and health
status or disease risk there is a need
for accurate monitoring of diet which
can be recorded using self-reported mea-
sures such as Food Frequency Question-
naires (FFQs), 24-h recall and diet di-
aries/records. However, these methods
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are subjective, misreporting is common and substantial and is
exacerbated in those who are overweight or obese.[3,4] Recent
research has demonstrated that metabolites derived from
individual foods present in urine samples provide potential
biomarkers of dietary exposure, and including such measure-
ments could overcome some of the limitations of traditional
dietary assessment methodologies by providing additional
objective estimates of food exposure.[5] A range of factors have
been proposed that need to be considered for the validation and
deployment of dietary exposure biomarkers.[6] Fully validated
dietary exposure biomarkers which are robust and reproducible
and have been tested in both free-living and controlled food
studies, within different food matrices are limited to a relatively
small number of specific foods and food components.[7–9] The
use of multi-metabolite biomarker panels may provide more
reliable estimation of dietary exposure than a single-biomarker
approach (reviewed by ref. 10). For dietary biomarkers to have
any significant utility, it is essential that their coverage is as
comprehensive as possible. Nationally representative estimates
of intakes of foods by the UK population are provided by the
UK National Diet and Nutrition Survey (NDNS),[11] and can be
explored to indicate where dietary exposure biomarker discovery
might be feasible and relevant.
Dietary exposure biomarkers ideally need to be suitable for
use in large-scale surveys and epidemiological studies. Any urine
sampling procedurewould need to be acceptable for volunteers to
provide repetitive samples and require minimal researcher time
but deliver samples with high-quality information content. To
date there are no studies focusing on dietary exposure biomarker
validation that have investigated specifically natural micturi-
tion behavior and acceptability of urine sampling methods in
free-living populations as a prelude to biomarker technology
deployment under real world conditions. A recent review of nu-
trimetabolomics suggested that first morning void, post-prandial
spot, or 24-h urines can be collected, depending on the purpose
of the study.[12] The “gold standard” method of requesting
participants to collect all urine over a 24-h period[13] provides a
substrate for accurate quantitation of food intake during a single
day using biomarkers, but imposes a significant burden on
participants by impacting on normal daily activities, as well as
being costly and logistically difficult to handle large volumes of
urines by both participants and researchers. Recently it has been
shown that spot fasting sample collections, which are low burden
for participants, can adequately discriminate exposure class for
several dietary components, and could possibly substitute for
24-h urine samples for biomarker discovery and habitual dietary
exposure measurements.[14] In acute food intervention dietary
biomarker discovery experiments, we have shown that 3-h
postprandial urines provided strong classification models[15] but
because urine composition was relatively stable over a period of
2–4 h after eating a meal, there may be a flexible time window for
urine collection.[16] The MAIN (Metabolomics at Aberystwyth,
Imperial and Newcastle) study aimed to identify foods and food
groups for which future biomarker detection and validation is
feasible and used this information to develop two complex 3-day
menu plans, in the context of conventional UK eating patterns.
Additionally we aimed to design and implement urine sampling
protocols and procedures which could be applied in future
large-scale epidemiological studies and public health surveys.
2. Subjects and Methods
2.1. Ethical Approval
A favorable ethical opinion was obtained following Proportion-
ate Review by the East Midlands - Nottingham 1 National Re-
search Ethics Committee (14/EM/0040). Caldicott approval for
storage of data and data protection was granted by Newcastle-
upon-Tyne Hospitals NHS Foundation Trust [6896(3109)]. The
trial was adopted into the UK Clinical Research Network (CRN)
Portfolio (16037) and is registered with International Standard
Randomized Controlled Trials Number (ISRCTN), 88921234. All
participants gave written informed consent, and the study was
carried out in accordance with the Declaration of Helsinki. In-
ternational Standard Randomized Controlled Trials Number (IS-
RCTN), 88921234.
2.2. Study Design and Urine Sampling
Previously, participant handling protocols were developed
in which acute exposure to specific foods of high public
health importance was investigated under carefully supervised
conditions.[16–18] Similar protocols were used in the present
study but they were adapted for use with free-living participants.
Some behavioral restrictions were imposed on volunteers on the
day preceding the test day. Participants were asked to restrict
physical activity and to avoid alcohol consumption and to restrict
polyphenol intake.
Foods/food groups were selected using information on con-
sumption frequencies, food groupings, and eating habits from
the UK NDNS years 1–3,[11] together with Public Health England
policy advice from The Eatwell Plate[19] which has now been re-
vised to The Eatwell Guide[20] (as described in the Results sec-
tion in Table 1 and Supporting Information 1). Standard portion
sizes were used based on the UK Food Standards Agency[21] or
manufacturers’ suggestions. Six different menu plans were de-
signed using a design strategy described in Supporting Informa-
tion 2, that were investigated in two dietary experimental peri-
ods in which healthy free-living adult participants (experimental
period 1, n = 15 where 53 female, non-smokers, age = 22–63;
experimental period 2, n = 36 where 58% female, non-smokers,
age= 19–77 years) were provided with all their food for the three
consecutive days (Table 2 shows an example menu plan and Sup-
porting Information 3 shows the full menu plans). A sample size
of 15 participants was aimed for in the first experimental period
1 and 30 participants in the second experimental period to allow
for a 20% drop out. This sample size was determined by the fea-
sibility of recruitment. The menu plans were designed to pro-
vide 4–5 key targeted foods each day (Supporting Information
1 and 2). Energy and macronutrient contents of the meals and
daily menus (Supporting Information 4) were calculated directly
from food packaging and by using the USDA National Nutrient
database (for perishable foods sold without packaging).[22]
The first day of the first experimental period 1 was based
largely on foods/food groups for which putative dietary expo-
sure biomarkerswere already available. The remaining fivemenu
plans aimed to deliver foods for new biomarker discovery, and
to consider the impact of the major sources of likely variance
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Table 1. Section of the database compiled for the selection of foods/food
groups for biomarker development Values in brackets are the percentage
of the population whom recorded consumption of the food item  1.
Food type Disaggregated food groups in
UK national diet and
nutrition survey (NDNS)
Top three food choices for
each NDNS food group
Fruit Fresh and canned fruit (92%) Bananas, raw
Fruit Eating apples, raw
Fruit White grapes, raw
Fruit Fruit juice (87%) Orange juice, UHT
Fruit Orange juice, pasteurized
Fruit Robinsons juice
Fruit Dried fruit (45%) Raisins
Fruit Sultanas
Fruit Stuffing (filling)
Vegetable Yellow/red & dark green leafy
vegetables (93%)
Carrots, boiled
Vegetable Peppers, red, boiled
Vegetable Carrots, uncooked
Vegetable Tomato (91%) Tomatoes, raw
Vegetable Baked beans
Vegetable Canned tomatoes
Vegetable Tomato puree (83%) Baked beans
Vegetable Tomato ketchup
Vegetable Cheese and tomato pizza
Vegetable Brassicaceae (64%) Broccoli spears, boiled
Vegetable Cauliflower, boiled
Vegetable Mixed leaf salad
Vegetable All other vegetables (97%) Onions, boiled
Vegetable Cucumber, raw
Vegetable Lettuce, raw
in biomarker monitoring and discovery, including impact of
complex and mixed meals, different food formulations, process-
ing, and cooking methods as well as the dynamics of putative
biomarker retention in the body. Menus plans were designed in
the context of conventional UK eating patterns viz. breakfast,
lunch, afternoon snack, and dinner (Figure 1). The first three
menu plans (in the first experimental period) were repeated by
the participants twice in the same order but a week apart. The re-
maining three menu plans (in the second experimental period)
were repeated by the participants three times in a randomized
3×3 Latin square design. Participants came to the Clinical Age-
ing Research Unit (CARU), Newcastle University on the day be-
fore the experimental period to collect foods in pre-determined
food portions or “ready meals” (as appropriate), and cooking in-
structions and to be briefed. These foods/drinks were prepared,
cooked, and consumed by participants at home. Participants were
requested not to consume any foods or drinks, including alcohol,
other than those provided by the research team and to eat the
meals within the stated times each day. Water, however, was al-
lowed ad libitum and participants were encouraged to remain hy-
drated throughout. Participants were requested to record the time
that they finished each meal and how much of each food/drink
item they ate and at what time. If some food was uneaten, the par-
Table 2. The menu plan for experimental day 1.
Meal Time Menu
Breakfast 08:00–10:00 Instant coffee
1 slice of sourdough rye bread toasted
with butter
Frosties with Semi skimmed UHT milk
Banana
Lunch 12:00–14:00 Instant coffee
Tuna chunks as a salad with lettuce,
onion and sweetcorn
2 slices of sourdough rye bread with
butter
Banana
Afternoon tea 16:00–16:30 Instant coffee
Banana loaf
Dinner 18:00–20:00 Grilled salmon steak with broccoli and
chips
Coca cola
Red wine
Almonds
Bottled water, throughout day and at
each meal time
ticipant recorded eating 75%, 50%, 25%, or 0%, as appropriate.
Participants recorded if they ate or drank any additional items or
prepared any of the meals differently from that instructed. Fur-
ther study details will be described in a future publication.
Urine samplingmethods were implemented based on the pre-
vious studies.[16,18] Participants were asked to collect urine sam-
ples after their evening meal (post-dinner), all urines overnight
including the first morning void (FMV), fasting, and post-
breakfast and post-lunch urine samples up to the day after the
completion of the menu plans (Figure 1). Participants collected
urine in a calibrated plastic jug and recorded the date, time, and
total volume of collection. A 20-mL aliquot from each urination
was retained and the rest discarded. If not at home, participants
kept urine samples in a cool bag, otherwise they stored them in
a refrigerator before returning them to the research team at the
end of each experimental week, where they were further stored
at −80 °C until analysis. An overnight urine sample was made
by pooling aliquots of each urine proportional to the volume of
urine collected after dinner, overnight and including the FMV
and stored at −80 °C.
2.3. Urine Sample Preparation and Adjustment
All urine samples were normalized by refractive index prior to
analysis to ensure allMSmeasurements weremadewithin a sim-
ilar dynamic range. Samples were defrosted overnight in a 4 °C
fridge. Once defrosted, samples were centrifuged (600 × g for 5
min at 4 °C), placed on ice and aliquots of thawed urine (1000 µL)
was transferred into labelled 2-mL Eppendorf tubes. The remain-
ing samples were returned to a −20 °C freezer. An OPTI Hand
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Figure 1. MAIN study experimental period. Participants were asked to consume a low polyphenol meal (provided or of the participants own choice) in
the evening prior to starting each 3-daymenu plan (pre-day). All foods and drinks for four meals each day for three consecutive days were provided. These
foods/drinks were prepared, cooked, and consumed by the participant at home. Participants were asked to collect all urines as separate “spot urines”
in specific time-windows including ( ) first morning void, FMV; (◦), fasting; (•) and post-prandial urines (post-breakfast, post-lunch, and post-dinner)
for the duration of the experimental period.
Held Refractometer (Bellingham Stanley Brix 54 Model) was cal-
ibrated with de-ionized water (dH2O) and dried with paper tis-
sue according to the manufacturer’s instruction. Following this
220 µL of sample was transferred onto the refractometer dish,
the specific gravity (SG) value was recorded in triplicate and tem-
perature was noted. The refractometer was rinsed with dH2O be-
tween samples and dried with tissue. Average SG values were cal-
culated. Based on these figures, aliquots of the required amounts
of urine from centrifuged 2-mL Eppendorf tubes and dH2Owere
transferred into new tubes for extraction.
2.4. Flow Infusion-High Resolution Fingerprinting (FIE-HRMS)
All urine samples were randomized according to meal day and
post-prandial time point to minimize batch effects and were an-
alyzed using high resolution (HR) flow infusion electrospray
(FIE) ionizationmass spectrometry (MS). 20 µL of extracted sam-
ple was transferred to a glass HPLC vial containing a 200 µL
flat bottom micro insert (Chromacol) and diluted with 80 µL of
H2O:MeOH (3:7) directly in the vial. Mass spectra were acquired
on an Exactive Orbitrap (ThermoFinnigan, San Jose CA) mass
spectrometer coupled to an Accela (ThermoFinnigan, San Jose
CA) ultra-performance liquid chromatography system. 20 µL of
sample was injected and delivered to the electrospray source via
a flow solvent (mobile phase) of pre-mixed HPLC grade MeOH
(Fisher Scientific) and ultra-pure H2O (18.2 ) at a ratio of 7:3.
The flow rate was 200 µL min−1 for the first 1.5 min, and 600 µL
min−1 for the remainder of the protocol, total time 3.0 min.
Positive and negative ionizationmodes were acquired simulta-
neously. For each ionizationmode, one scan event was used to ac-
quire all mass spectra, 55.000–1000.000m/z and 63.000–1000.00
m/z for positive and negative mode respectively. The scan rate
was 1.0 Hz. Mass resolution was 100 000, with automatic gain
control 5×105 andmaximum injection time 250ms, for both ion-
ization modes. Following data acquisition, raw profile data (.raw;
ThermoFinnigan) were converted to the .mzML open file format
and centroided[23] using msconvert (TransProteomicPipeline).[24]
All further processing of mzML files was performed using the R
Statistical Programming Language using the R package binneR
(Version 1.1.0).[25]
Dimensionality reduction of the acquired mass spectra was
performed by taking each m/z value from scans about the apex
of the infusion profile and binning the m/z and intensity values
at 0.01 amu intervals, allowing direct comparison of urine finger-
prints, prior to signal annotation. The result was an n x pmatrix,
where n is the sample and p is the m/z feature and cells are the
respective average intensity values. The resulting matrices con-
sisted of 4552 features and 4857 features for positive and negative
ionization modes respectively. The total number of observations
for each ionization mode was 633.
2.5. Multivariate Modelling and Classification
Principal Component Analysis (PCA) was followed by PC-Linear
Discriminant Analysis (PC-LDA). PCA was performed using the
prcomp function inR.[25] Intra-batch variancewas removed adjust-
ing intensity values by the mean value of the respective analytical
block (where each block contains an equal representation of the
total biological variance). Prior to statistical analysis, data was
normalized to the total ion count (TIC) of the sample. For multi-
variate analysis (PCA and PC-LDA) all samples and features were
used. Plots of the first two PC-Discriminant Functions (PC-DFs)
Mol. Nutr. Food Res. 2019, 63, 1900062 1900062 (4 of 9) C© 2019 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
www.advancedsciencenews.com www.mnf-journal.com
allowed visualization of the goodness of class separation as quan-
tified by Tw values (Eigenvalues). Supervised RandomForest (RF)
classification was implemented using the randomForest package
in R.[25] For all Random Forest models, the number of trees
(ntree) used was 1000 and the number of variables considered at
each internal node (mtry) was the square root of the total number
of variables. Accuracy, margins of classification, and area under
the ROC (Receiver Operator Characteristic) curve (AUC) were
used to evaluate the performance of classification models, as pre-
viously described.[26] Models were deemed adequate overall if RF
margins> 0.2 and AUC values> 0.8, as it has been implemented
previously.[26,27]
2.6. Quantification Using Ultra High Performance Liquid
Chromatography (UHPLC)
Biomarkers were quantified in urine samples by a procedure
based on Multiple Reaction Monitoring.[28] Analyses were
performed on a TSQ Quantum Ultra triple quadrupole (QQQ)
mass spectrometer (Thermo Scientific), equipped with a heated
electro-spray ionization (HESI) source and coupled to an Accela
UHPLC system (Thermo Scientific). Columns used for separa-
tion of individual biomarkers together with retention times are
shown in Supporting Information 5. For HILIC (Hydrophilic
Interaction Liquid Chromatography) analysis, chromatographic
separation was performed on a ZIC-pHILIC (polymeric 5 µm,
150 × 4.6 mm) column (Merck). The mobile phase consisted of
A) 10 mm ammonium acetate in water: acetonitrile (95:5) and
B) 10 mm ammonium acetate in water: acetonitrile (5:95). The
gradient program used was as follows: 0 min, 95% B (400 µL
min−1); 15 min, 20% B (400 µL min−1); 15.01 min, 20% B
(500 µL min−1); 20 min, 20% B (500 µL min−1); 20.01 min, 95%
B (500 µLmin−1); 25 min, 95% B (500 µLmin−1). The HPLC was
carried out in low pressure (0–7000 psi) operating mode with 0
and 650 bar as minimum and maximum pressures, respectively.
For reverse phase (RP) analysis, chromatographic separation was
performed on Hypersil Gold (1.9 µm, 200×2.1 mm2) (Thermo
Scientific). The mobile phase consisted of A) 0.1% formic acid in
H2O and B) 0.1% formic acid in MeOH. The gradient program
used was as follows: 0 min, 0% B; 0.5 min, 0% B; 5 min, 60% B;
11 min, 100% B; 13 min, 100% B; 13.01 min, 0% B; 19 min, 0%
B. For RP analysis, the flow rate wasmaintained at 400 µLmin−1.
The UHPLC was carried out in high pressure (7000–15 000
psi) operating mode with 0 and 1000 bar as minimum and
maximum pressures, respectively. For both chromatographic
analyses, column oven and autosampler tray were maintained at
60 and 14 °C, respectively. To ensure consistent sample delivery,
20 µL were injected using a 20 µL loop and partial loop injection
mode. After each injection, syringe and injector were cleaned us-
ing a 10%HPLC grade MeOH solution in ultra-pure water (1 mL
flush volume) to avoid sample carryover. Spectra were collected at
a scan speed of 0.010 and 0.003 s for HILIC and RP analysis, re-
spectively. A scan width of 0.010 u, and peak width (Q1, Q3) of 0.7
FWHMwere used for both HILIC and RP analyses. Mass spectra
were acquired in multiple reaction monitoring (MRM) mode,
in positive and negative ionization mode simultaneously using
optimized values of shimmer offset, collision energy, and tube
lens for each MRM transition (see Supporting Information 5 for
transitions). Limit-of-detection (LOD) and limit-of-quantification
(LOQ) are shown in Supporting Information 5. Absolute
concentrations were calculated using a nine-point calibration
curve (0.006561 to 100 µg mL−1) for each biomarker). Mean
concentration of biomarkers for selected dietary components
between the different menus plans were tested for significance
using the paired t-test significance values. Xcalibur (V3.0.63,
Thermo Fisher Scientific Inc.) was used for peak integration, cal-
ibration, and quantification. A squared fit of log 10-transformed
values accommodated best the wide concentration range for
biomarkers in high and low consumers, without compromising
accuracy and normal distribution requirements for regression
analysis.
3. Results
3.1. Selection of Foods/Food Groups Used in Menu Design for
Urine Biomarker Discovery and Validation
Current approaches used for biomarker discovery generally in-
volve metabolomic comparisons of samples derived from either
controlled dietary interventions or cross-sectional studies. Sup-
porting Information 6 summarizes the major characteristics of
typical dietary exposure biomarker discovery strategies. In most
instances significant validation challenges remain, particularly
in relation to biomarker specificity and sensitivity in the context
of normal population eating behavior. Here we used quantitative
information on individual-level food intake in the UK[11] and UK
healthy eating advice[19] (Table 1 and Supporting Information 1)
to select candidate foods/food groups for incorporation into two
complex 3-day experimental periods in the context of conven-
tional UK eating patterns. Importantly this included information
on cooking/preparation methods of commonly consumed foods
which we used to test biomarker generalizability by using
different formulations/cooking/processing methods for these
foods. As an example, the fruit and vegetable subsection of the
database is shown in Table 1. The menu design strategy, which
is further described in Supporting Information 2, revealed target
foods and food groups for incorporation into the menu design
to facilitate future biomarker discovery for these food groups
(Table 2 and Supporting Information 3). We aimed to incorporate
the most commonly consumed foods in each category using the
same cooking/processing methods as reported in the NDNS
data (Table 2 as an example of 1 menu plan and Supporting
Information 3).
3.2. Validation of Acceptability of Menu Design
Participants recorded how much of each food/drink item they
consumed and this compliance information is summarized in
Supporting Information 7. Overall, there was a high compliance
(>80%) for each food item in all menus. The lowest mean com-
pliance was for instant coffee (80%), followed by soya milk drink
and apple pie (both 82%).
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Figure 2. Timings of post-prandial urine sample collections for 15 partic-
ipants following menu plans 1–3 over two weeks (expressed as a percent
of collections at each time-point).
3.3. Developing a Strategy for Collection of Informative Spot
Urine Samples at Home
We calculated the compliance of urine sample collections for 15
participants following menus 1–3 over two weeks. The most suc-
cessful urine type collected was FMV and the post-dinner spot
sample (both at 99% compliance). Post-prandial samples had a
compliance of between 92–99% (Post-breakfast, 93%, Post-lunch
92% and post-dinner, 99%). The fasting sample was the least suc-
cessfully collected sample (86%). Most urine samples were col-
lected between 2 and 4 h after each main meal (breakfast, lunch,
and dinner; Figure 2). On some occasions, participants collected
multiple post-breakfast and post-lunch urine samples (8% and
16%, respectively), when only a single sample was requested.
In addition, on 75% of occasions, participants collected multiple
post-dinner samples as requested in the protocol. The overnight
micturition patterns (data shown in Supporting Information 8)
were evenmore variable between individuals. Themost common
number of urines produced after the evening meal was 3 or 4
(28% and 32% respectively) reaching a maximum of 6 in 3% of
study group.
3.4. Metabolome Fingerprint Analysis to Assess Compositional
Similarities between Urine Types
Metabolome fingerprints were generated by non-targeted FIE-
HRMS to determine the chemical compositional similarity be-
tween the behavioral phase urine types using supervised, mul-
tivariate classification tools including Random Forest (RF) and
Principal Component Linear Discriminant Analysis (PC-LDA).
Where multiple post-prandial spot urine samples were collected,
we selected the urine sample closest to the >2.0, 3.0 h win-
dow, after consumption of the meal. Classification performance
can be assessed from sample clustering behavior in scores plots
representing the first two discriminant functions (DFs) and from
quantitative modelling output measures including RF margin
values and AUC values.[26] In both positive (Figure 3A) and neg-
ative (Figure 3B) ionization modes urine fingerprints showed
characteristic differences in the composition of urines collected
at different times on one experimental day and the following
FMV and fasting urines collected the next morning. The FMV
and fasting urines collected on the experimental day overlapped
(i.e., were compositionally similar) as were the FMV and fasting
urines collected the next morning (with RF margins <0.2 and
AUC values <0.8 as shown in Supporting Information 9). Post-
breakfast and post-lunch samples clustered together with poor
classification RF margins and AUC values, but were distinctive
from the post-dinner urine samples, with RF margins >0.2 and
AUC values>0.8 (Supporting Information 9). Although the post-
dinner, overnight, and next morning FMV samples showed loose
Figure 3. Principal component-linear discriminant analysis (PC-LDA) scores plots of flow infusion electrospray ionization-high resolution mass spec-
trometry (FIE-HRMS) fingerprints of each urine sample collected on the experimental day and the FMV and fasting urines collected the next morning
for 15 participants following menu plan 1 A) positive ionization mode; B) negative ionization mode. PC-Discriminant Function (PC-DF) Eigenvalues (Tw
values) are given in brackets; x, baseline first morning void;, baseline fasting; , post-breakfast; *, post-lunch; ◦, bed-time/post-dinner;,overnight,
next day first morning void; +, next day fasting.
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Table 3. Concentration in first morning void (FMV) urine samples of proposed biomarkers after consumption of target foods compared to the baseline
levels when the food of interest was not consumed, or consumed in a low amount.
Food Proposed biomarker Concentration in FMV urine the
day after consumption
[µg mL−1, ± st error]
Baseline concentration
in FMV urine
Coffee Feruloylglycine[35] 0.78 ± 0.17** 0.11 ± 0.02
Wholegrain DHPPA -3-sulfate[31] 1.32 ± 0.16** 0.28 ± 0.02
Broccoli SFN-NAC[29] 1.35 ± 0.26** 0.03 ± 0.00
Fish TMAO[15,32] 41.83 ± 4.79** 9.71 ± 1.02
Poultry and oily fish L-Anserine[15,32] 3.97 ± 1.69* 0.30 ± 0.05
Sweetened foods Sucrose[30] 0.28 ± 0.14 0.54 ± 0.15
DHPPA, 3-(3,5-dihydroxyphenyl)-1-propanoic acid; TMAO, trimethylamine-N-oxide; SFN-NAC, D,L-sulforaphane-N-acetyl-L-cysteine; Paired t-test (n = 15) **, p-value <0.01;
*, p-value <0.05.
clustering (Figure 3), there are clearly substantial compositional
differences, especially in negativemode (Supporting Information
9).
These data suggest that in a real world situation participants
would not need to adhere to collecting spot urine samples at
strictly pre-determined times; there would be room for some de-
viation based on substantial phases (several hours) of the day.
These data demonstrated potential for a reduced sampling pro-
cedure for both biomarker discovery and for informative habitual
dietary exposure measurements in future clinical trials and nu-
tritional status surveys.
3.5. Validation of Study Design Performance of Existing
Biomarkers Using Spot FMV Samples
The first menu plan (n = 15) (Table 2) included instant coffee,
wholegrain (sourdough rye bread), high-sugar food (sweetened
breakfast cereal), oily fish (salmon and tuna), a cruciferous veg-
etable (broccoli), foods for which putative biomarkers have been
identified.[15,29–35] Using UHPLC-MS/MS we observed higher
concentrations of the known biomarkers for coffee, wholegrain,
fish, poultry, and broccoli in FMV urine on the day post con-
sumption of these foods compared with baseline concentrations
on a day when the foods were not consumed, or consumed in a
low amount (Table 3). In contrast there was no significant differ-
ence in sucrose concentrations after consumption of sweetened
breakfast cereal compared with other menu plans. The means
and standard errors for eachmenu day, with the selected reaction
monitoring (SRM) fragments, LOD and LOQ values are shown
in Supporting Information 5.
4. Discussion
Currently, chemical biomarkers suitable for monitoring dietary
exposure are limited to a relatively small number of specific foods
and food components.[7–9] Dietary intervention approaches gen-
erally used for biomarker discovery usually involve participants
consuming a single test food in isolation in a single meal[36]
or repeated foods[37] or repeated meals with single food com-
ponents altered.[15,29] Here we used quantitative information on
individual-level food intake in the UK[11] and UK healthy eat-
ing advice[19] (Table 1 and Supporting Information 1) to select
candidate foods/food groups for incorporation into two complex
3-day experimental periods in the context of conventional UK
eating patterns. Importantly this included information on cook-
ing/preparation methods of commonly consumed foods which
we used to test biomarker generalizability by using different for-
mulations/cooking/processing methods for these foods. Analy-
sis of the database (Table 1 and Supporting Information 1) re-
vealed target foods and food groups for incorporation into the
menu design to facilitate future biomarker discovery for these
food groups (Table 2 and Supporting Information 3).
Individuals in their home-settings adhered to the menus suc-
cessfully, with more than 80% of all food items consumed. The
lowest acceptability was for instant coffee but it should be noted
participants were asked to consume three cups of instant coffee
in that experimental menu and that consumption at breakfast
and lunchtime (97% and 85% consumption, respectively) was
much higher than that for the third cup (80%) consumed in the
evening. The overall high compliance (80%) for consumption
of all food items on the menus provided a robust basis for inves-
tigation urine samples by metabolomic approaches.
To be useful for biomarker-based monitoring of food intake, a
urine sampling procedure should be acceptable for participants,
require minimal researcher time and deliver samples with
high-quality information content. Since 24-h urine collections
are laborious and unacceptable to some participants,[38,39] we
determined the utility and acceptability of a urine sampling
protocol in the home environment based on the collection of
spot samples (Figure 1). Participants were asked to consume
the test meals at pre-determined times and to collect spot urine
samples within particular time-windows to investigate which
urine samples are most useful for identifying putative biomark-
ers of recent exposure to target foods. Metabolome fingerprints
of urine samples were generated by non-targeted FIE-HRMS.
Our data suggest that collection of spot FMV and post-dinner
urine samples, rather than overnight or 24 h collections would
ensure increased compliance. This would reduce participant
burden and would be less intrusive for participants sampling
urines in their own home in future by requesting only a spot
FMV and/or a post-dinner sample rather than the collection of
24 h urine. It been has shown previously that the information
content of overnight pools and spot fasting urine samples could
all adequately discriminate exposure class for several dietary
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components, and could possibly adequately substitute for 24-h
urines.[14]
The metabolite composition of FMV was generally chemically
different from both the overnight and post-dinner urine collec-
tions and varied due to food consumed on the previous menu
plan day. The post-dinner urine represents acute exposure to all
foods consumed over the day and the FMV contains these same
acute signals and biotransformed derivatives thereof, in addition
to representing the activity of the gut microbiome on food in-
gested the day before. By looking at the micturition timings and
success rate of urine sampling from the first 15 participants it was
indicated that the most successful urine type collected was FMV
and the post dinner spot sample (both at 99% compliance), when
compared with fasting and the other post-prandial urines. We
demonstrated that there was an overlap in chemical composition
between two pairs of behavioral phase urine types, namely: FMV
and fasting, and then the post-breakfast and post-lunch sample
(Supporting Information 9). This suggests that in a real world
situation participants would not need to adhere to collecting spot
urine samples at strictly pre-determined times; there would be
room for some deviation based on substantial phases (several
hours) of the day. This demonstrated value for a reduced sam-
pling procedure for both biomarker discovery and validation and
for informative habitual dietary exposure measurements in fu-
ture clinical trials and nutritional status surveys.
Our data support the hypothesis that the chemical composi-
tion of a spot sample of FMV urine is suitable for identifying
biomarkers of commonly consumed foods. Urinary concentra-
tions of reported biomarkers in Table 3 were increased signif-
icantly after consumption of the specific food when compared
with experimental day 2 and/or 3 when the food was not con-
sumed. Several biomarkers remained significantly increased af-
ter a further menu plan for reasons including repeat exposure
to foods (i.e., Wholegrain: DHPPA-sulfate and Poultry and Fish:
anserine) and possibly slower biomarker clearance rate (i.e., Cof-
fee: feruloylglycine and Fish: TMAO). There was no significant
difference for sucrose[30] after menu plan 1 compared with other
menu plans possibly due to the moderate sugar content of many
foods and beverages being consumed on all three days.
By showing that the FMV and post-dinner urine were themost
successful urine types collected by the participants, we propose
that in future population health surveys, the request for either
replicate FMV and/or post-dinner urine collections would ensure
increased compliance from participants. By collecting spot FMV
and post-dinner urine samples only, rather than overnight or 24-
h collections, we feel it is less intrusive for volunteers and de-
livers samples with value both for biomarker discovery and vali-
dation and for informative dietary exposure measurements. The
urine sampling protocols and procedures we designed and im-
plemented could be applied in future large-scale epidemiolog-
ical studies and public health surveys, focusing on approaches
that were easy to use, acceptable to the general public and which
would be of modest cost.
To summarize, we developed a food exposure strategy follow-
ing a conventional UK eating pattern for biomarker-lead discov-
ery and validation in free-living individuals. A urine sampling
methodology has been evaluated for free-living study participants
that is non-intrusive and imposes low burden, and showed that
FMV spot urine had good information content in regard to di-
etary exposure. This study design is expected to have value for
both biomarker validation and for informative habitual dietary
exposure measurements in epidemiological studies and in pop-
ulation health surveys.
Supporting Information
Supporting Information is available from the Wiley Online Library or from
the author.
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